Grace Therapeutics, Inc.

GRCE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Jan 28, 2026
8-K Jan 12, 2026 8-K
4 Jan 12, 2026 FORM 4
4 Jan 12, 2026 FORM 4
4 Jan 12, 2026 FORM 4
4 Jan 12, 2026 FORM 4
10-Q/A Nov 17, 2025 10Q/A
SCHEDULE 13G/A Nov 14, 2025
8-K Nov 13, 2025 8-K
10-Q Nov 13, 2025 10-Q
8-K Oct 23, 2025 8-K
8-K Sep 18, 2025 8-K
8-K Sep 12, 2025 8-K
8-K Aug 27, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
8-K Aug 12, 2025 8-K
10-Q Aug 12, 2025 10-Q
DEFA14A Jul 28, 2025 DEFA14A
DEF 14A Jul 28, 2025 DEF 14A
8-K Jun 25, 2025 8-K
8-K Jun 23, 2025 8-K
10-K Jun 23, 2025 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D)
SCHEDULE 13G/A May 15, 2025
SCHEDULE 13G May 15, 2025
4 May 13, 2025 FORM 4
← Newer Page 3 of 24 · 599 filings Older →